LOVINDA IWHERE: Open Payments
NPI 1760709612 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,382 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 3 | $183 |
| SCPHARMACEUTICALS INC. | 1 | $150 |
| Neurocrine BioSciences, Inc. | 1 | $136 |
| Astellas Pharma US Inc | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $122 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $109 |
Products named: Dyanavel XR, FUROSCIX, Veozah, Descovy, Auvelity.
Industry payments across GA — which companies pay providers there.
